.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Management of Diabetes and Renal Impairment

Robert Busch; MD, Dhiren Patel, PharmD, CECES, BC-ADM; and Muthiah Vaduganathan, MD, MPH, review the role of SGLT-2 inhibitors in renal protection in patients with and without diabetes.

EP 1: Overview of Diabetes and Renal Impairment

October 29th 2021

Dhiren Patel, PharmD, CECES, BC-ADM, Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, provide an overview of the prevalence of renal impairment in patients with diabetes.

EP 2: Risks and Complications for Chronic Kidney Disease

October 29th 2021

An expert endocrinologist and cardiologist discuss the risks and complications of renal disease associated with diabetes and cardiovascular disease. Dr Robert Busch also provides an overview of some of the studies done in renal impairment.

EP 3: Importance of Education on Reducing Renal Progression

October 29th 2021

Dr Robert Busch and Dr Muthiah Vadugananthan provide insights on educating their peers on the importance of decreasing renal progression.

EP 4: Managing Renal Impairment with Multiple Agents

October 29th 2021

Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, share their thoughts on the multifunctional responsibility of managing a patient’s renal disease.

EP 5: Case Study: Reducing Renal Progression With SGLT-2 Inhibitors

October 29th 2021

A case study for a patient who required additional SGLT-2 inhibitors to help reduce progression of renal disease is presented, and Drs Robert Busch, Dhiren Patel, and Muthiah Vadugananthan share their final thoughts on renal protective agents.